Suboxone (Buprenorphine/Naloxone Film) Lawsuit (MDL-3092) — Eligibility, Settlement Updates, and How to File

Suboxone (buprenorphine/naloxone film) lawsuit claims allege that the sublingual film used to treat opioid use disorder caused severe dental injuries. Thousands of patients report tooth decay, cavities, and tooth loss after using this dissolving medication. The litigation is consolidated in federal court in Ohio. In January 2022, the FDA issued a formal warning about dental risks linked to buprenorphine medicines dissolved in the mouth. As a result, affected individuals began filing claims. The suboxone (buprenorphine/naloxone film) lawsuit now includes over 1,800 pending federal cases.

Case Timeline

Last checked: July 10, 2026

Advertisement

  • July 10, 2026 (Bellwether Date): First bellwether trial remains projected for March 2028, with core discovery depositions set to run July 13, 2026 through January 15, 2027 and the four final bellwether cases to be selected June 11, 2027. (Court Record)
  • July 10, 2026 (Ruling): Under Judge J. Philip Calabrese’s amended bellwether protocol (CMO No. 15), the parties finalized the 50-case Core Discovery Pool with the final Core Discovery list due to the court July 2, 2026. (Court Record)
  • July 10, 2026 (Ruling): Judge Calabrese compelled several record custodians to produce documents and scheduled a contempt hearing for July 1, 2026 for non-compliant providers. (Court Record)
  • July 10, 2026 (Case Status): Pending cases stand at approximately 1,833 as of June 1, 2026, a slight decline driven by dismissals for failure to comply with prior court orders. (Court Record)
  • July 10, 2026 (Settlement): No global settlement is being negotiated and no settlement framework has been announced; defendants are not expected to offer one until bellwether cases reach juries. (Court Record)
  • June 26, 2026 (Bellwether Date): Judge Calabrese set a bellwether schedule with 20 random case selections on June 10, 2026, 15 picks per side on June 24, and the final Core Discovery list due July 2, 2026. (Court Record)
  • June 26, 2026 (Bellwether Date): Core discovery depositions will run July 13, 2026 through January 15, 2027, with the Trial Pool narrowed to 15 cases on January 29, 2027 and four final bellwether cases selected June 11, 2027. (Court Record)
  • June 26, 2026 (Bellwether Date): First Suboxone bellwether trial is now projected for early 2028 (around March 2028). (Court Record)
  • June 26, 2026 (Ruling): Judge Calabrese compelled several entities to produce dental/medical records and scheduled a contempt hearing for July 1, 2026 for non-compliant providers amid ongoing records-collection delays. (Court Record)
  • June 26, 2026 (Case Status): As of June 1, 2026, 1,833 lawsuits are pending in MDL-3092 (N.D. Ohio), with nearly 11,000 Suboxone dental claims filed nationwide. (Court Record)
  • June 26, 2026 (Settlement): No court-approved settlements have been announced for the Suboxone dental MDL, and no settlement framework is in place as of June 2026. (Court Record)
  • June 12, 2026 (Case Status): As of June 1, 2026, there are 1,833 lawsuits pending in MDL-3092 (up from ~900 in mid-2025), consolidated before Judge J. Philip Calabrese in the Northern District of Ohio. (Court Record)
  • June 12, 2026 (Ruling): On February 25, 2026, Judge Calabrese held an in-person status conference and issued a case management order detailing procedures for selecting and managing bellwether trial plaintiffs. (Court Record)
  • June 12, 2026 (Bellwether Date): The court randomly selected 500 cases for a record collection pool; plaintiff fact sheets and evidence were due April 20, 2026, with defense disclosures due May 20, 2026, to narrow the pool to 15 representative bellwether cases. (Court Record)
  • June 12, 2026 (Bellwether Date): Bellwether trials are set for late 2026; the court is in the discovery and case-selection phase as of June 2026. (Court Record)
  • June 12, 2026 (Settlement): No formal settlement framework has been announced; settlement estimates from legal analysts range $50,000–$150,000 per plaintiff depending on individual dental injury severity. (Court Record)
  • June 12, 2026 (Other): Key defendants are Indivior Inc., Indivior Solutions Inc., and Aquestive Therapeutics Inc., accused of failing to warn about severe dental injuries from the sublingual film formulation. (Court Record)
  • June 05, 2026 (Bellwether Date): The first bellwether trial is projected for March 2028; the court ordered 20 cases randomly selected from a 100-case pool for core discovery by June 10, 2026, with 15 preferred representative cases to be identified by July 2, 2026. (Court Record)
  • June 05, 2026 (Ruling): Defendants (Indivior Inc. and Aquestive Therapeutics) must provide defense disclosures by May 20, 2026; depositions run through January 15, 2027, and dispositive motions are due by March 12, 2027. (Court Record)
  • June 05, 2026 (Bellwether Date): The court expects to narrow the bellwether pool to four final cases by June 11, 2027, ahead of the projected March 2028 trial. (Court Record)
  • June 05, 2026 (Settlement): No global settlement has been announced; law firms estimate individual Suboxone settlements in the range of $50,000–$150,000 per plaintiff based on case severity. (Court Record)
  • June 05, 2026 (Other): Suboxone tooth decay lawyers are scheduled to meet with Judge Calabrese to review the 2026 MDL schedule and upcoming discovery milestones. (Court Record)
  • June 01, 2026: FAQ: Can I Sue Suboxone for Ruining My Teeth? – robertkinglawfirm.com (robertkinglawfirm.com)
  • May 22, 2026 (Ruling): Judge Calabrese is overseeing bellwether selection; no specific trial start date has been publicly scheduled yet as the MDL remains in the discovery and case-management phase. (Court Record)
  • May 22, 2026 (Settlement): No global settlement framework has been announced; legal analysts estimate individual settlements in the range of $50,000–$150,000 depending on severity of dental injuries. (Court Record)
  • May 22, 2026 (Other): Key defendants are Indivior Inc. and Aquestive Therapeutics Inc., accused of failing to warn about dental risks of Suboxone sublingual film despite knowing about acidic formulation dangers. (Court Record)
  • May 22, 2026 (Other): Suboxone tooth decay lawyers met with the judge to review the 2026 MDL schedule, indicating active case management and preparation for bellwether proceedings. (Court Record)
  • July 24, 2025: Suboxone Tooth Decay Lawsuit: May 2026 Updates – Drugwatch.com (Drugwatch.com)
  • February 13, 2026: 100 Suboxone Film Tooth Decay Lawsuits Selected for Next Phase of Bellwether Discovery – AboutLawsuits.com (AboutLawsuits.com)
  • May 15, 2026 (Case Status): As of March 2, 2026, there are 1,853 lawsuits pending in MDL-3092 before Judge J. Philip Calabrese in the Northern District of Ohio. (Court Record)
  • May 15, 2026 (Bellwether Date): Plaintiff fact sheets and supporting evidence were due April 20, 2026, with defense responses due May 20, 2026; bellwether trials expected mid-2026 from a pool narrowed to 15 representative cases. (Court Record)
  • May 15, 2026 (Ruling): Judge Calabrese ordered a bellwether selection process: 500 cases randomly selected for record collection, narrowed to 100 for deeper fact-gathering, then 15 for potential bellwether trials. (Court Record)
  • May 15, 2026 (Settlement): No global settlement has been reached; estimated individual settlement values range from $50,000 to $150,000 (up to $500,000+ for severe cases), but no framework has been announced. (Court Record)
  • May 15, 2026 (Other): Defendants are Indivior Inc. and Aquestive Therapeutics Inc.; core claims allege failure to warn about dental risks (tooth decay, erosion, fractures, tooth loss) from the acidic film formulation. (Court Record)
  • What Is the Suboxone (Buprenorphine/Naloxone Film) Lawsuit About?

    MDL Detail Current Data
    MDL Number MDL-3092
    Pending Cases 1,832
    Presiding Judge TBD
    Federal District TBD
    Data Source U.S. Judicial Panel on Multidistrict Litigation
    Last Updated July 06, 2026

    Suboxone is a prescription medication that combines buprenorphine and naloxone. It comes as a dissolvable film placed under the tongue. Doctors prescribe it to treat opioid use disorder and manage withdrawal symptoms. The film dissolves in the mouth over several minutes. During that time, acidic compounds in the medication contact teeth and gums directly.

    Plaintiffs in the suboxone (buprenorphine/naloxone film) lawsuit allege that this prolonged acid exposure causes serious dental harm. Reported injuries include tooth decay, enamel erosion, cavities, tooth fractures, oral infections, and complete tooth loss. For example, some patients experienced severe dental damage within just two weeks of starting treatment. Others developed problems over months or years of regular use.

    The defendants in this litigation are Indivior Inc., Indivior Solutions Inc., and Aquestive Therapeutics Inc. Plaintiffs claim these manufacturers knew about the dental risks. However, they failed to warn patients and prescribers adequately. The FDA identified 305 cases of buprenorphine-related dental problems before issuing its 2022 safety warning. Of those, 131 were classified as severe. Seventy-one required tooth extractions.

    MDL Case Status and Key Facts

    The Judicial Panel on Multidistrict Litigation consolidated all federal Suboxone dental injury cases into MDL-3092. Judge J. Philip Calabrese presides over the litigation in the Northern District of Ohio. The suboxone (buprenorphine/naloxone film) lawsuit MDL continues to grow as new plaintiffs join the proceeding.

    Detail Information
    MDL Number 3092
    Presiding Judge Judge J. Philip Calabrese
    Federal District Northern District of Ohio
    Approximate Pending Cases 1,832+
    Estimated Individual Claims 20,000+
    Defendants Indivior Inc., Indivior Solutions Inc., Aquestive Therapeutics Inc.
    First Bellwether Trials Projected for March 2028

    In 2026, the court established an updated bellwether schedule. A 50-case Core Discovery Pool will be selected starting June 2026. Core discovery depositions will run from July 2026 through January 2027. The court will narrow the group to a 15-case Trial Pool by late January 2027. Four final bellwether trial cases will be selected by June 2027. The first trials are projected for March 2028.

    However, the actual number of affected individuals is much higher than the docket count suggests. Many filings include dozens of plaintiffs in a single case. As a result, industry estimates suggest over 20,000 individual claims exist within the MDL.

    Who Qualifies for the Suboxone (Buprenorphine/Naloxone Film) Lawsuit?

    You might be eligible to file a suboxone (buprenorphine/naloxone film) lawsuit claim if you meet certain criteria. Typically, you must have used the Suboxone sublingual film formulation. You must also have experienced dental problems during or after treatment. Common qualifying injuries include tooth decay, cavities, tooth fractures, tooth loss, and oral infections.

    In most cases, claimants need dental records documenting their injuries. Medical records showing Suboxone film prescriptions are also important. The stronger your documentation, the better your position. However, even patients with no prior history of dental problems may qualify. The FDA’s 2022 warning confirmed that these injuries can occur regardless of previous dental health.

    The formulation of Suboxone matters as well. Claims generally involve patients who used the film version. The tablet version is not part of this litigation. If you believe you qualify, consulting a licensed attorney is strongly recommended. An experienced lawyer can evaluate your specific situation and advise on next steps.

    How to File a Suboxone (Buprenorphine/Naloxone Film) Lawsuit Claim

    Filing a suboxone (buprenorphine/naloxone film) lawsuit claim typically begins with a free case evaluation. Many mass tort law firms offer no-cost consultations. During this review, an attorney will assess your medical history, dental records, and Suboxone usage. This step helps determine whether you have a viable claim.

    After retaining an attorney, you will complete a Plaintiff Fact Sheet. This document gathers detailed information about your Suboxone use and dental injuries. Your lawyer will then file your case in the MDL-3092 proceeding. As a result, your claim joins the consolidated litigation in Ohio.

    📨 Get Free Mass Tort Guides Alerts

    Free · No spam · Unsubscribe anytime

    The statute of limitations varies by state. Many states apply the discovery rule. This means the clock starts when you knew or should have known about the injury. For example, some states had two-year deadlines that expired in 2024. Others with three-year limits saw deadlines pass in 2025. However, exceptions may still apply in certain circumstances. A qualified attorney can determine whether your claim remains timely. Do not delay in seeking legal advice.

    Settlement Updates and What to Expect

    As of May 2026, no global settlement has been reached in the suboxone (buprenorphine/naloxone film) lawsuit. Settlement negotiations typically accelerate after bellwether trial results are known. With the first trials projected for March 2028, formal talks may still be some time away.

    However, this litigation follows a familiar pattern seen in other mass tort MDLs. In most cases, these proceedings resolve through negotiated settlements after bellwether verdicts establish case values. Over 95 percent of mass tort cases ultimately settle before going to full trial. The bellwether process helps both sides understand the range of likely outcomes.

    Settlement amounts in the suboxone (buprenorphine/naloxone film) lawsuit will likely vary widely. The severity of dental injuries plays a major role. Treatment costs, out-of-pocket expenses, and the duration of Suboxone use all factor into individual valuations. No one should expect guaranteed compensation. Every case is unique, and outcomes depend on individual circumstances. Consulting a licensed attorney remains the best way to understand what you may be entitled to recover.

    State-by-State Considerations

    State tort reform laws can significantly affect your suboxone (buprenorphine/naloxone film) lawsuit claim. Each state has its own rules on damages caps, statutes of limitations, and liability standards. For example, Ohio, Pennsylvania, and Florida have notable plaintiff counts in this MDL. California and New York also contribute significant numbers of claims. Tort reform measures in certain states may limit specific types of recoverable damages.

    These state-level differences can impact potential compensation. Some states cap non-economic damages such as pain and suffering. Others apply comparative fault rules that may reduce awards. Typically, an attorney licensed in your state can explain how local laws affect your case. Understanding these distinctions is important before filing any claim.

    Frequently Asked Questions

    Is the Suboxone lawsuit only about the film version of the medication?

    Yes. The suboxone (buprenorphine/naloxone film) lawsuit focuses specifically on the sublingual film formulation. The dissolvable film makes prolonged acidic contact with teeth and gums. The tablet version dissolves differently and is not included in this litigation.

    How long will the Suboxone MDL take to resolve?

    The timeline remains uncertain. Bellwether trials are projected for March 2028. Settlement discussions typically follow trial outcomes. As a result, final resolution could take several more years. However, the case is actively progressing through discovery and pretrial procedures.

    Can I still file a Suboxone lawsuit in 2026?

    It depends on your state’s statute of limitations and when you discovered your injury. Some filing deadlines have passed in certain states. However, the discovery rule may extend filing windows for some plaintiffs. Contact a licensed attorney promptly to evaluate whether your claim remains viable.

    Check If You May Qualify

    Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.

    Official Sources & Resources

    For verified mass tort and MDL information:

    Content last reviewed May 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.

    Related Guides

    Going through divorce too? Compare state laws at Divorce Help Guide. Affected by a recalled drug as a Medicare patient? See Medicare Cover Guide. Just diagnosed with a serious illness? Compare life insurance at Life Insure Guide. PFAS in your water? Check homeowners coverage at Home Insure Guide.